Aug 5 (Reuters) - Pharmaxis Ltd PXS.AX :
* Pharmaxis and Synairgen announce research collaboration to develop loxl2 inhibitor for pulmonary fibrosis
* Source text for Eikon IDnASX82TBfx:
*
Aug 5 (Reuters) - Pharmaxis Ltd PXS.AX :
* Pharmaxis and Synairgen announce research collaboration to develop loxl2 inhibitor for pulmonary fibrosis
* Source text for Eikon IDnASX82TBfx:
*